69 related articles for article (PubMed ID: 8994328)
1. Examination of pericardial effusions by cytology and immunocytochemistry.
Chen LM; Chao TY; Chiang JH; Nieh S; Chang JY; Hwang SH; Hseuh EJ; Wang CC
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Oct; 58(4):248-53. PubMed ID: 8994328
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens.
Saab J; Hoda RS; Narula N; Hoda SA; Geraghty BE; Nasar A; Alperstein SA; Port JL; Giorgadze T
Cancer Cytopathol; 2017 Feb; 125(2):128-137. PubMed ID: 28207201
[TBL] [Abstract][Full Text] [Related]
3. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.
Rossi ED; Bizzarro T; Schmitt F; Longatto-Filho A
Cancer Cytopathol; 2015 Apr; 123(4):258-66. PubMed ID: 25641902
[TBL] [Abstract][Full Text] [Related]
4. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
5. Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions.
Chen CJ; Chang SC; Tseng HH
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Sep; 54(3):149-55. PubMed ID: 7954054
[TBL] [Abstract][Full Text] [Related]
6. Pericardial fluid cytology: an analysis of 128 specimens over a 6-year period.
Dragoescu EA; Liu L
Cancer Cytopathol; 2013 May; 121(5):242-51. PubMed ID: 23362233
[TBL] [Abstract][Full Text] [Related]
7. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
8. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
Kundu R; Handa U; Mohan H
Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
[TBL] [Abstract][Full Text] [Related]
9. A Minimum Volume of More Than 60 mL Is Necessary for Adequate Cytologic Diagnosis of Malignant Pericardial Effusions.
Rooper LM; Ali SZ; Olson MT
Am J Clin Pathol; 2016 Jan; 145(1):101-6. PubMed ID: 26712877
[TBL] [Abstract][Full Text] [Related]
10. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
Su XY; Li GD; Liu WP; Xie B; Jiang YH
Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
[TBL] [Abstract][Full Text] [Related]
11. Clinico-cytopathologic analysis of 574 Pericardial Effusion Specimens: Application of the international system for reporting serous fluid cytopathology (ISRSFC) and long-term clinical follow-up.
Song MJ; Jo U; Jeong JS; Cho KJ; Gong G; Cho YM; Song JS
Cancer Med; 2021 Dec; 10(24):8899-8908. PubMed ID: 34747147
[TBL] [Abstract][Full Text] [Related]
12. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions.
Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G
Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775
[TBL] [Abstract][Full Text] [Related]
13. Cytology of pericardial effusions in AIDS patients.
Zakowski MF; Ianuale-Shanerman A
Diagn Cytopathol; 1993; 9(3):266-9. PubMed ID: 8390928
[TBL] [Abstract][Full Text] [Related]
14. Secondary pericardial malignancies: a critical appraisal of the role of cytology, pericardial biopsy, and DNA ploidy analysis.
Bardales RH; Stanley MW; Schaefer RF; Liblit RL; Owens RB; Surhland MJ
Am J Clin Pathol; 1996 Jul; 106(1):29-34. PubMed ID: 8701928
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic value of pericardial cytology. An analysis of 95 cases.
Wiener HG; Kristensen IB; Haubek A; Kristensen B; Baandrup U
Acta Cytol; 1991; 35(2):149-53. PubMed ID: 2028688
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of malignant pericarditis: a single centre experience.
Pawlak Cieślik A; Szturmowicz M; Fijałkowska A; Gątarek J; Gralec R; Błasińska-Przerwa K; Szczepulska-Wójcik E; Skoczylas A; Bilska A; Tomkowski W
Kardiol Pol; 2012; 70(11):1147-53. PubMed ID: 23180523
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of primary cardiac lymphoma. Report of a case with cytologic examination of pericardial fluid and imprints of transvenously biopsied intracardiac tissue.
Chao TY; Han SC; Nieh S; Lan GY; Lee SH
Acta Cytol; 1995; 39(5):955-9. PubMed ID: 7571977
[TBL] [Abstract][Full Text] [Related]
20. Cytopathology of pericardial effusions : Experience from a tertiary center of cardiology.
Gecmen C; Gecmen GG; Ece D; Kahyaoğlu M; Kalayci A; Karabay CY; Candan O; Isik ME; Yilmaz F; Akgun O; Celik M; Izgi IA; Kirma C; Keser S
Herz; 2018 Sep; 43(6):543-547. PubMed ID: 28695237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
